Performance of integrated positron emission tomography/computed tomography for mediastinal nodal staging in non-small cell lung carcinoma.
SR Broderick, GA Patterson - Thoracic surgery clinics, 2013 - europepmc.org
Integrated positron emission tomography (PET)/CT is routinely used for mediastinal nodal
staging of non-small cell lung carcinoma in centers throughout the world. This modality is the …
staging of non-small cell lung carcinoma in centers throughout the world. This modality is the …
Accuracy of computed tomography and magnetic resonance imaging in staging bronchogenic carcinoma
R Manfredi, T Pirronti, L Bonomo, P Marano - … Resonance Materials in …, 1996 - Springer
Sixty-three patients with non-small cell bronchogenic carcinoma were prospectively and
independently assessed by computed tomography (CT) and magnetic resonance imaging …
independently assessed by computed tomography (CT) and magnetic resonance imaging …
The new staging system for lung cancer: imaging and clinical implications
SM Greaves, K Brown, EB Garon… - Journal of thoracic …, 2011 - journals.lww.com
Accurate staging of lung cancer is necessary to describe and communicate disease extent,
predict prognosis, determine therapy, and evaluate the results of clinical trials. The Union …
predict prognosis, determine therapy, and evaluate the results of clinical trials. The Union …
Mediastinal staging of non-small cell lung carcinoma using computed and positron-emission tomography
PD Kiernan, MJ Sheridan, J Lamberti… - Southern medical …, 2002 - go.gale.com
Background. We evaluated the accuracy of computed tomography (CT) and positron-
emission tomography (PET) in the mediastinal staging of non-small cell lung cancer …
emission tomography (PET) in the mediastinal staging of non-small cell lung cancer …
Mediastinal staging of non-small-cell lung cancer with positron emission tomography.
R Chin Jr, R Ward, JW Keyes, RH Choplin… - American journal of …, 1995 - atsjournals.org
To determine the usefulness of positron emission tomography with fluoro-2-deoxyglucose
(PET-FDG) in assessing mediastinal disease in patients with non-small-cell lung cancer …
(PET-FDG) in assessing mediastinal disease in patients with non-small-cell lung cancer …
Bronchogenic carcinoma staging: CT versus MR imaging. Assessment with surgery
F Laurent, J Drouillard, F Dorcier… - European journal of …, 1988 - academic.oup.com
One hundred and twenty patients with bronchogenic carcinoma wereprospectively studied
by both computed tomography (CT) and magneticresonance imaging (MRI) during the 2 …
by both computed tomography (CT) and magneticresonance imaging (MRI) during the 2 …
Integrated PET/CT in lung cancer imaging: history and technical aspects.
W De Wever, S Stroobants… - JBR-BTR: Organe de la …, 2007 - europepmc.org
Integrated PET/CT is a new anatomo-metabolic imaging modality combining two different
techniques: Computed Tomography (CT) that provides very detailed anatomic information …
techniques: Computed Tomography (CT) that provides very detailed anatomic information …
Non–small cell lung cancer: dual-modality PET/CT in preoperative staging
G Antoch, J Stattaus, AT Nemat, S Marnitz, T Beyer… - Radiology, 2003 - pubs.rsna.org
PURPOSE: To determine the accuracy of dual-modality positron emission tomographic
(PET)–computed tomographic (CT) imaging, as compared with PET alone and CT alone, in …
(PET)–computed tomographic (CT) imaging, as compared with PET alone and CT alone, in …
Clinical staging of patients with non-small cell lung cancer
AG Little, FP Stitik - Chest, 1990 - Elsevier
This article is the first in a planned series from the Section on Lung Cancer of the ACCP
addressing the important and clinically relevant aspects of what is now the most common …
addressing the important and clinically relevant aspects of what is now the most common …
Imaging of lung cancer: Implications on staging and management
NC Purandare, V Rangarajan - Indian Journal of Radiology and …, 2015 - thieme-connect.com
Lung cancer is one of the leading causes of cancer-related deaths. Accurate assessment of
disease extent is important in deciding the optimal treatment approach. To play an important …
disease extent is important in deciding the optimal treatment approach. To play an important …